Trial Profile
Efficacy of telmisartan versus calcium channel antagonists in patients with hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2011
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Calcium channel antagonists
- Indications Hypertension
- Focus Therapeutic Use
- 05 Jan 2011 New trial record